【Mitsui Chemicals】2026 Fiscal Year Financial Results｜Sales of 166.8 billion yen (Down 7.8% YoY)

Performance Overview

Mitsui Chemicals achieved net sales of 166.8 billion yen (down 7.8% YoY) for the fiscal year ending March 2026, with net income attributable to parent company shareholders totaling 3.44 billion yen (up 6.6% YoY). The Life & Healthcare Solutions segment maintained growth in both revenue and profit, while Mobility Solutions experienced a decrease in sales and profit due to lower sales volume. Overall, core operating profit was steady at 100.0 billion yen (down 0.9% YoY), and dividends increased to 37.5 yen. Moving forward, the company aims to enhance business transformation while carefully monitoring raw material prices and currency fluctuations amid global economic uncertainties.

Outlook and Shareholder Returns

The earnings forecast for the fiscal year ending March 2027 anticipates sales of 190.0 billion yen (up 13.9% YoY) and net income of 4.5 billion yen (up 30.9% YoY), with an annual dividend of 75 yen planned. In the medium to long term, Mitsui Chemicals will promote ESG management and optimize its business structure, continuing stable dividends and share buybacks as shareholder return policies. The company will also focus on cost control and fostering new business opportunities to prepare for fluctuations in currency rates and raw material prices.